Pneumonitis in Patients with Lung Cancer Following Treatment: the Effects of Chemotherapy, Immunotherapy, and Tyrosine Kinase Inhibitors

This publication has 59 references indexed in Scilit:

• Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer
  Journal of Cancer Research and Clinical Oncology, 2011
• Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)
  Annals of Oncology, 2009
• Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study
  Annals of Oncology, 2009
• tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation
  British Journal of Cancer, 2008
• Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
  Gynecologic Oncology, 2008
• Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901
  Journal of Thoracic Oncology, 2008
• Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature
  International Journal of Gynecological Cancer, 2006
• Interstitial Lung Disease Induced by Drugs and Radiation
  Respiration, 2004
• A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin
  Cancer, 2002
• Diffuse alveolar damage in a patient treated with gemcitabine
  European Respiratory Journal, 1998